Tygh Capital Management’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q1
Sell
-118,214
Closed -$2.78M 78
2019
Q4
$2.78M Buy
+118,214
New +$2.78M 0.46% 70